Durect Corp (DRRX) Stock Price, Quote & News

Company Profile

DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company's lead product candidate includes larsucosterol, an endogenous, orally bioavailable small molecule to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as for the treatment of patients with metabolic dysfunction-associated steatohepatitis. The company also offers POSIMIR,...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 408 777 1417

Fax: 408 777 3577

Website: www.durect.com

Address:

10240 Bubb Road, Cupertino, United States

TheContrarianOne Jun. 16 at 11:44 PM

$DRRX Volume drying up after the recent rally after it hit support at $0.50. Good news for shorts.

0 · Reply

TheContrarianOne Jun. 14 at 12:46 AM

$DRRX Any CEO giving himself $1.5 million a year when his company is losing essentially $10 million a year, with no foreseeable future of profit and a minuscule $8 million in cash on hand should be immediately investigated. Very clear what this company is. It’s an ATM for the c-suite masquerading as a bio pharmaceutical company.

1 · Reply

TheContrarianOne Jun. 13 at 10:08 PM

$DRRX This company is complete dogs shit. Shorted 10,000 shares today. Covered my short in $XFOR at a 30% gain over the past 2 weeks and moved on to this.

1 · Reply

norbertm Jun. 12 at 4:21 PM

$DRRX I dreamt for some reason we got a gamma squeeze with float recycled 300x times and SP up 3000%. And I still did not sell 🤣.

1 · Reply

Anakin95 Jun. 12 at 7:25 AM

$DRRX still up lets take it higher today

0 · Reply

ccarrera Jun. 11 at 2:32 PM

$DRRX buying back in happily

1 · Reply

Glene Jun. 5 at 2:00 PM

$DRRX Does anyone have information as to where they stand on acquiring funding

3 · Reply

Anakin95 Jun. 3 at 8:21 PM

$DRRX up up

0 · Reply

mnps Jun. 2 at 11:13 AM

$DRRX It has been radio silence for months. Anybody heard anything? I still think a mouse study to look at longevity would be worth the minimal cost. Look at the drugs actions... Sell to the masses, eat with the classes. Sell to the classes, eat with the masses. There are one hell of a lot more customers outside of liver failure!

1 · Reply

DMONEY1337 May. 28 at 7:24 PM

$DRRX I got 12k right below .50 today. Im the last one here buying and its right where I like to be.

1 · Reply

DURECT Corporation Reports First Quarter 2025 Financial Results and Provides Business Update

Mar 26, 2025, 8:04 PM EDT - 2 months ago

DURECT Corporation (DRRX) Q4 2024 Earnings Call Transcript

Mar 26, 2025, 4:05 PM EDT - 2 months ago

DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 19, 2025, 4:30 PM EDT - 3 months ago

DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update

Feb 4, 2025, 7:30 AM EST - 4 months ago

DURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

Jan 28, 2025, 10:09 AM EST - 4 months ago

DURECT Corporation Announces Publication of Larsucosterol Phase 2b Results in NEJM Evidence

Nov 25, 2024, 6:00 AM EST - 7 months ago

DURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 Million

Nov 13, 2024, 10:17 PM EST - 7 months ago

DURECT Corporation (DRRX) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 4:01 PM EST - 7 months ago

DURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 6, 2024, 4:45 PM EST - 7 months ago

DURECT Corporation to Announce Third Quarter 2024 Financial Results and Provide a Business Update

Oct 17, 2024, 8:30 AM EDT - 8 months ago

DURECT Corporation to Present Data on Larsucosterol at The Liver Meeting 2024

Sep 25, 2024, 8:00 AM EDT - 9 months ago

DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated Hepatitis

Sep 4, 2024, 4:30 PM EDT - 10 months ago

DURECT Corporation to Present at the H.C. Wainwright Global Investment Conference

Aug 13, 2024, 8:42 PM EDT - 10 months ago

DURECT Corporation (DRRX) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 4:01 PM EDT - 10 months ago

DURECT Corporation Reports Second Quarter 2024 Financial Results and Business Update

Aug 7, 2024, 4:30 PM EDT - 11 months ago

DURECT Corporation to Announce Second Quarter 2024 Financial Results and Provide a Business Update

May 21, 2024, 8:00 AM EDT - 1 year ago

DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis

May 13, 2024, 9:54 PM EDT - 1 year ago

DURECT Corporation (DRRX) Q1 2024 Earnings Call Transcript

May 13, 2024, 4:05 PM EDT - 1 year ago

DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update

May 7, 2024, 4:30 PM EDT - 1 year ago

DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update

Apr 30, 2024, 7:00 AM EDT - 1 year ago

DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis

Mar 27, 2024, 6:07 PM EDT - 1 year ago

DURECT Corporation (DRRX) Q4 2023 Earnings Call Transcript

Mar 27, 2024, 4:01 PM EDT - 1 year ago

DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Mar 20, 2024, 4:30 PM EDT - 1 year ago

DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update

Mar 4, 2024, 7:00 AM EST - 1 year ago

DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and Canada

Feb 7, 2024, 6:48 PM EST - 1 year ago

DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Dec 18, 2023, 7:39 AM EST - 1 year ago

Top 3 Health Care Stocks That Are Preparing To Pump This Month - Durect (NASDAQ:DRRX), Aadi Bioscience (NASDAQ:AADI)

Nov 13, 2023, 6:50 PM EST - 1 year ago

DURECT Corporation (DRRX) Q3 2023 Earnings Call Transcript

Nov 13, 2023, 4:05 PM EST - 1 year ago

DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update

Nov 9, 2023, 4:30 PM EST - 1 year ago

DURECT Corporation to Announce Third Quarter 2023 Financial Results and Provide a Business Update

Nov 7, 2023, 4:01 PM EST - 1 year ago

DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis with Promising Effect on Mortality

Sep 7, 2023, 7:00 AM EDT - 1 year ago

DURECT Corporation Announces Last Patient Last Visit in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis

Aug 31, 2023, 4:30 PM EDT - 1 year ago

DURECT Corporation Announces Presentations in Upcoming Investor Conferences

Aug 9, 2023, 8:22 PM EDT - 2 years ago

DURECT Corporation (DRRX) Q2 2023 Earnings Call Transcript

Aug 9, 2023, 4:05 PM EDT - 2 years ago

DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update

Aug 3, 2023, 4:30 PM EDT - 2 years ago

DURECT Corporation to Announce Second Quarter 2023 Financial Results and Provide a Business Update

Jul 20, 2023, 8:00 AM EDT - 2 years ago

DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jun 7, 2023, 6:00 AM EDT - 2 years ago

DURECT Completes Enrollment in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis

May 8, 2023, 10:42 PM EDT - 2 years ago

DURECT Corporation (DRRX) Q1 2023 Earnings Call Transcript

May 8, 2023, 4:05 PM EDT - 2 years ago

DURECT Corporation Reports First Quarter 2023 Financial Results and Business Update

May 1, 2023, 7:03 PM EDT - 2 years ago

DURECT Corporation to Announce First Quarter 2023 Financial Results and Provide Business Update on May 8

Apr 27, 2023, 5:11 PM EDT - 2 years ago

DURECT Corporation to Host KOL Event on Alcohol-Associated Hepatitis

Apr 25, 2023, 6:45 PM EDT - 2 years ago

DURECT Corporation to Participate in Fireside Chat at the H.C. Wainwright BioConnect Investor Conference

Apr 10, 2023, 6:00 AM EDT - 2 years ago

DURECT Announces Peer-Reviewed Article Accepted for Publication with Additional Data from Previously Completed Phase 2a Study of Larsucosterol in Alcohol-Associated Hepatitis

Mar 21, 2023, 4:30 PM EDT - 2 years ago

DURECT Corporation Announces Appointment of Gail Maderis as Chair of the Board

Mar 9, 2023, 8:30 AM EST - 2 years ago

DURECT Corporation Fireside Chat at the Oppenheimer 33rd Annual Healthcare Conference

Mar 7, 2023, 6:46 PM EST - 2 years ago

DURECT Corp (DRRX) Q4 2022 Earnings Call Transcript

Mar 7, 2023, 4:05 PM EST - 2 years ago

DURECT Corporation Reports Fourth Quarter and Full Year 2022 Financial Results and AHFIRM Trial Update

Feb 28, 2023, 6:07 PM EST - 2 years ago

DURECT Corporation to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 7

Feb 3, 2023, 5:17 PM EST - 2 years ago

DURECT Corporation Announces $10 Million Registered Direct Offering of Common Stock and Warrants

TheContrarianOne Jun. 16 at 11:44 PM

$DRRX Volume drying up after the recent rally after it hit support at $0.50. Good news for shorts.

0 · Reply

TheContrarianOne Jun. 14 at 12:46 AM

1 · Reply

TheContrarianOne Jun. 13 at 10:08 PM

$DRRX This company is complete dogs shit. Shorted 10,000 shares today. Covered my short in $XFOR at a 30% gain over the past 2 weeks and moved on to this.

1 · Reply

norbertm Jun. 12 at 4:21 PM

$DRRX I dreamt for some reason we got a gamma squeeze with float recycled 300x times and SP up 3000%. And I still did not sell 🤣.

1 · Reply

Anakin95 Jun. 12 at 7:25 AM

$DRRX still up lets take it higher today

0 · Reply

ccarrera Jun. 11 at 2:32 PM

$DRRX buying back in happily

1 · Reply

Glene Jun. 5 at 2:00 PM

$DRRX Does anyone have information as to where they stand on acquiring funding

3 · Reply

Anakin95 Jun. 3 at 8:21 PM

$DRRX up up

0 · Reply

mnps Jun. 2 at 11:13 AM

1 · Reply

DMONEY1337 May. 28 at 7:24 PM

$DRRX I got 12k right below .50 today. Im the last one here buying and its right where I like to be.

1 · Reply

DMONEY1337 May. 28 at 1:48 PM

$DRRX Anyone who really knows this asset knows this is a great place to buy. Firesale price is several multiples of current MC.

0 · Reply

DMONEY1337 May. 23 at 1:40 PM

$DRRX Generational buying opportunity here. Worst case is a buy out on the very low end of estimates (100M). Best case they enter into a strategic partnership with big pharma and real value is unblocked once a competent team is involved.

1 · Reply

KINGSPARTAN May. 22 at 7:58 PM

$DRRX well, I believe this may be my last post. Continued decrease in share price on higher volume not good. I have tried to warn you Longs for years about this company, its pathetic management and BOD, the lack of getting anything AH across the finish line, the disrespect to you shareholders, lack of follow thru and business savvy, shady business, the ones who continued to mislead you, etc. But you would not listen. Now the share price sits at about three shiny copper pennies higher than making a new ALL TIME LOW. Best of luck to you who still remain. My work is done.

1 · Reply

KINGSPARTAN May. 22 at 7:51 PM

$DRRX Longs, while @DMONEY1337 posts garbage from an AI bot named Grok and misleads you all to think that there is hope in this still below would give you a true response from a AI bot, if you believe in this stuff: “In summary, when a small biotech company experiences increased volume and decreasing share price, it's a warning sign that should be taken seriously. It can indicate negative sentiment, potential financial difficulties, or a weakening of investor confidence, all of which can have long-term consequences for the company's growth and stability.” Furthermore why would this joker post this anyway when they sold out of their position not long ago. Remember the post from @Biomd12 the other day. Both are one and the same. Two different screen names but same person.

0 · Reply

DMONEY1337 May. 22 at 12:38 PM

$DRRX From Grok: A reasonable acquisition valuation for DURECT Corporation, considering Larsucosterol’s potential in AH, the AHFIRM trial results, and the market opportunity, is $250–$450 million. This range balances the strong clinical data (especially U.S. subgroup results), FDA designations, and blockbuster potential against clinical and financial risks. A strategic acquirer with a focus on hepatology or orphan drugs might lean toward the higher end, while a more conservative buyer might target the lower end.

2 · Reply

sawbone57 May. 21 at 8:33 PM

$DRRX with this volume and price action on no news I’ve got the sinking feeling some shark is gobbling us up and we’re ALL gonna get screwed even if this drug successfully launches.

1 · Reply

bnjhnsn May. 21 at 12:40 AM

$DRRX volume is trending upwards as price is slowly slipping. Not saying what is going to unfold here, as confidence is extremely low, would love to add if i could

1 · Reply

sawbone57 May. 19 at 11:28 PM

$DRRX hopefully once this plays out we will get some clarity on why this unconscionable delay occurred. Thousands of patients have died waiting on “the deal”. I fully believed in the science and the leadership team’s ability to get this drug to market. Hell, even the stodgy old FDA believed, granting fast track AND breakthrough status to this drug. Now, all I have is disgust.

0 · Reply

DMONEY1337 May. 19 at 8:22 PM

$DRRX Conversation with Timmy (Tiny Tim) Papp. Remain hopeful that a deal will be done to unlock value. The market thinks they are going BK but a surprise deal will wake this up.

0 · Reply

brunoq14 May. 16 at 12:49 PM

$DRRX Going concern warning. May not have sufficient funds for another year.

0 · Reply

KINGSPARTAN May. 15 at 8:21 PM

$DRRX slow drip down Longs. One RED day after another. this week almost giving back all the gains from last week. volume up and down all week. big players getting out even at 100 share increments. poor management and poor business practices along with an incompetent CEO, CFO and failed scientists have brought the company down.

0 · Reply

KINGSPARTAN May. 15 at 8:14 PM

$DRRX appears @DMONEY1337 has finally sold out of any positions, this true by the latest post by @Biomd12 last post. appears he has finally taken down that unsightly picture of Brown as well and his love for him has finally diminished. he is now one of the smart ones. the puzzling piece is why was he just posting recently about a deal being announced soon and the reason for no quarterly call was because they were wanting to release on one call? yep, one of the many misleading junkies on this forum for a long time. best to you @Biomd12 , I meant @DMONEY1337

0 · Reply

Market Cap	19.09M
Revenue (ttm)	2.03M
Net Income (ttm)	-8.32M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-409.85%
Debt to Equity Ratio	0.00

Volume	17,400
Avg Vol	125,276
Day's Range	N/A - N/A
Shares Out	31.04M
Stochastic %K	64%
Beta	0.59
Analysts	Strong Sell
Price Target	$5.00